Who Can Participate?
Age Range
18-110
Sex/Genders
Male (cisgender)
Female (cisgender)
Non-binary or gender fluid
Transgender male
Transgender female
Looking for Healthy Participants
No
What is Involved?
Locations
Duke University Hospital
Visit Timing
Weekdays
Compensation
No
Spanish Materials Available
Yes
Study Details
Full Title
Protocol A082402, “Involved-Station, Intensity-Modulated Post-Operative Radiation Therapy (I²-Port) for Resected Non-Small Cell Lung Cancer with Residual Mediastinal Adenopathy after Neoadjuvant Therapy (ypn2))
Principal Investigator
Trey
Mullikin
Protocol Number
PRO00121091
NCT ID
NCT07293247
Phase
II
Enrollment Status
Open to Enrollment